Fatmanur Köktaşoğlu

Fatmanur Köktaşoğlu

Auto-generated profile, based on publicly available information

Fatmanur Köktaşoğlu

Department of Medical Biochemistry, Faculty of Medicine, Bezmialem Vakıf University, İstanbul, Turkey

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2023 in Scandinavian Journal of Gastroenterology
Verified
Journal Article
Closed access
MDMetin Demirel
Metin Demirel
FKFatmanur Köktaşoğlu
Fatmanur Köktaşoğlu
EÖEsin Özkan
Esin Özkan
HAHalime Dulun Ağaç
Halime Dulun Ağaç
AGAyşe Zehra Gül
Ayşe Zehra Gül
ŞSŞahabettin Selek
Şahabettin Selek
Non-alcoholic fatty liver disease (NAFLD) is a disease characterized by the accumulation of excessive fat in the liver, which can lead to fibrosis and has an increasing prevalence. NAFLD requires non-invasive diagnostic biomarkers. While typically observed in overweight individuals, it can also occur in non-obese/non-overweight individuals. Comparative studies on non-obese NAFLD patients are scarce. This study aimed to conduct a using liquid chromatography-high resolution mass spectrometry (LC-MS/MS)-based metabolic profiling of non-obese NAFLD patients and healthy controls. The patient group consisted of 27 individuals with NAFLD, while the healthy control group included 39 individuals. Both groups were between 18 and 40 years old, had a BMI of less than 25 and had alcohol consumption less than 20 g/week for men and 10 g/week for women. Serum samples were collected and analyzed using LC-MS/MS. The data were analyzed using the TidyMass and MetaboAnalyst. The LC-MS/MS analyses detected significant changes in D-amino acid metabolism, vitamin B6 metabolism, apoptosis, mTOR signaling pathway, lysine degradation, and phenylalanine metabolism pathways in non-obese NAFLD patients. Significant changes were also observed in the metabolites D-pantothenic acid, hypoxanthine, citric acid, citramalic acid, L-phenylalanine, glutamine, and histamine-trifluoromethyl-toluidide, β-hydroxymyristic acid, DL-Lactic acid, and 3-methyl-2-oxopentanoic. Overall, the study provides valuable insights into the metabolic changes associated with non-obese NAFLD patients and can contribute to the development of non-invasive diagnostic biomarkers for NAFLD. This study sheds light on the metabolic changes in non-obese NAFLD patients. Further research is needed to better understand the metabolic changes associated with NAFLD and to develop effective treatment options.

29 June 2023 in Journal of Chemical Metrology
Verified
Journal Article
Closed access
MDMetin Demirel
Metin Demirel
AGAyşe Zehra Gül
Ayşe Zehra Gül
FKFatmanur Köktaşoğlu
Fatmanur Köktaşoğlu
HAHalime Ağaç
Halime Ağaç
AGAhmet Ceyhan Goren
Ahmet Ceyhan Goren
ŞSŞahabettin Selek
Şahabettin Selek
Iron deficiency anemia is a prevalent type of anemia globally, caused mainly by the deficiency of iron, which is an essential component of various metabolic pathways. In this study, we aimed to investigate the changes in metabolite profiles resulting from alterations in these interconnected pathways. We selected 48 patients with IDA and 48 healthy participants based on diagnostic criteria for iron deficiency. NMR spectroscopy was utilized for metabolite profiling. Chenomx, MetaboAnalyst, and R were employed for data analysis. NMR analysis identified and quantified 119 metabolites. Significant metabolites between the two groups were determined using fold change (FC) analysis and t-test results. The FC values of the metabolite group ranked the following compounds in descending order: Acetoin, 2-Hydroxy-3-methylvalerate, Homogentisate, 3-Methylxanthine, Desaminotyrosine, Succinate, Methylguanidine, Guanidinosuccinate, 3-Methylglutarate, Ethanol, Carnosine, SN-Glycero-3-phosphocholine, and Homocysteine. The IDA patients had increased levels of Acetoin, 2-Hydroxy-3-methylvalerate, Homogentisate, 3-Methylxanthine, Succinate, Guanidinosuccinate, Ethanol, Carnosine, and SN-Glycero-3-phosphocholine, while decreased levels of Desaminotyrosine, Methylguanidine, and 3-Methylglutarate were observed. Our findings provide valuable insights into the different metabolites and pathways associated with IDA. Further molecular research is needed to validate these findings.

27 December 2023 in Acta Medica
Verified
Journal Article
Open access
PDF file
VYVildan Betül Yenigün
Vildan Betül Yenigün
AKAbdurrahim Kocyigit
Abdurrahim Kocyigit
EKEbru Kanımdan
Ebru Kanımdan
EDEzgi Durmus
Ezgi Durmus
FKFatmanur Koktasoglu
Fatmanur Koktasoglu
Aim: Glioblastoma, known for its aggressiveness, accounts for most malignant gliomas and the efficiency of its treatment is still not enough showing remarkably poor prognosis even though a complex treatment approach. Hedera helix is an evergreen plant mostly known for its effects on respiratory function, especially in chronic bronchial asthma, as well as its antimicrobial, anti-inflammatory, antioxidant, and potential antitumor properties, while its effect on glioblastoma cancer and the underlying mechanism has not been elucidated yet. The aim of this study was to examine the anti-cancer properties of Hedera helix (common ivy) in relation to its ability to induce cytotoxicity, apoptosis, and reactive oxygen species production in glioblastoma (U87) cells. Material and Methods: The leaves’ ethanol, methanol, and water extracts were analyzed for phenol, flavonoid, and antioxidant levels through photometric methods. Then, different concentrations of ethanol extract were applied to U87 cells for 24 hours and analyzed for cytotoxic, apoptotic, and ROS-generating effects by measuring the luminometric intracellular ATP amount, Acridine Orange/Ethidium Bromide double staining, and DCFH-DA methods, respectively. Results: Phenol, flavonoid, and antioxidant results of all three extracts show that ethanol was best for extraction. The results showed that Hedera helix ethanol extract had dose-dependent cytotoxic and apoptotic effects with increased intracellular ROS levels. Conclusion: These results concluded that high doses of Hedera helix ethanolic extract may exhibit anti-cancer effects through pro-oxidant activity.

19 June 2025 in Reproductive Sciences
Verified
Journal Article
Open access
PDF file
MDMetin Demirel
Metin Demirel
MAMehtap Alim
Mehtap Alim
FKFatmanur Koktasoglu
Fatmanur Koktasoglu
NANil Atakul
Nil Atakul
EGEbru Guner
Ebru Guner
SSSahabettin Selek
Sahabettin Selek
Background: Infertility affects approximately 15% of reproductive-age couples, with polycystic ovary syndrome and poor ovarian reserve being major contributing factors. Metabolomic profiling of follicular fluid offers insights into the underlying metabolic disturbances associated with these infertility phenotypes. This study aims to identify metabolic biomarkers distinguishing PCOS, POR, and male factor infertility, which may facilitate improved diagnostic and therapeutic strategies. Methods: A total of 119 participants were categorized into three groups: PCOS (n = 39), POR (n = 40), and NOR (n = 40). Liquid chromatography–high-resolution mass spectrometry was used for untargeted metabolomic profiling. Metabolites were identified using HMDB, MassBank, and MoNA, while pathway analysis was performed using KEGG. Statistical analyses were conducted using R and Python, including one-way ANOVA, t-tests, and Mann-Whitney U tests, with False Discovery Rate correction applied. Results: Distinct metabolic alterations were observed among the groups. Trehalose-6-phosphate, taurocholate, and N,N-dimethylglycine emerged as the most significantly altered metabolites, showing strong discriminatory potential between PCOS and POR. PCOS patients exhibited reduced levels of taurocholate, mycalemide, and trehalose-6-phosphate, whereas NOR patients showed elevated levels of N,N-dimethylglycine and argininosuccinate. The POR group demonstrated increased levels of 1-methyl-2-pyrrolidone and haplopine, along with a broader metabolite distribution. Conclusion: This study reveals phenotype-specific metabolic signatures in PCOS and POR, identifying taurocholate, mycalemide, and N,N-dimethylglycine as potential follicular biomarkers. These findings contribute to a deeper understanding of the metabolic basis of infertility and highlight the potential of follicular fluid metabolomics for precision medicine in reproductive health.

14 April 2022 in Bezmialem Science
Verified
Journal Article
Closed access
CKCumali Karatoprak
Cumali Karatoprak
AŞAbdusselam Şekerci̇
Abdusselam Şekerci̇
TKTahsin Karaaslan
Tahsin Karaaslan
AOAtilla Olgaç
Atilla Olgaç
ÖÖÖmer Faruk Özer
Ömer Faruk Özer
IEIskender Ekinci
Iskender Ekinci

1 May 2022 in Istanbul Medical Journal
Verified
Journal Article
Closed access
NANil Atakul
Nil Atakul
ŞSŞahabettin Selek
Şahabettin Selek
FKFatmanur Yılmaz Köktaşoğlu
Fatmanur Yılmaz Köktaşoğlu
BKBerna Şermin Kılıç
Berna Şermin Kılıç
AGAyşe Zehra Gül
Ayşe Zehra Gül
YAYıldız Atamer
Yıldız Atamer